VERVE THERAPEUTICS INC's ticker is VERV and the CUSIP is 92539P101. A total of 125 filers reported holding VERVE THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.44 and the average weighting 0.3%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARCH Venture Management, LLC | 2,008,809 | $28,967,026 | 13.98% |
| Alphabet Inc. | 10,549,086 | $152,117,820 | 8.44% |
| MPM BioImpact LLC | 803,501 | $11,586,484 | 3.01% |
| Casdin Capital, LLC | 2,120,571 | $30,578,634 | 2.52% |
| Novo Holdings A/S | 1,200,000 | $17,304,000 | 1.14% |
| Redmile Group, LLC | 1,120,679 | $16,160,191 | 0.70% |
| Avidity Partners Management LP | 1,351,700 | $19,491,514 | 0.65% |
| ARK Investment Management | 4,482,091 | $64,631,752 | 0.44% |
| BVF INC/IL | 650,000 | $9,373,000 | 0.34% |
| Cormorant Asset Management, LP | 350,000 | $5,047 | 0.33% |